101 related articles for article (PubMed ID: 14695165)
1. Hyper-recombination and genetic instability in BLM-deficient epithelial cells.
Traverso G; Bettegowda C; Kraus J; Speicher MR; Kinzler KW; Vogelstein B; Lengauer C
Cancer Res; 2003 Dec; 63(24):8578-81. PubMed ID: 14695165
[TBL] [Abstract][Full Text] [Related]
2. Bloom syndrome, genomic instability and cancer: the SOS-like hypothesis.
Amor-Guéret M
Cancer Lett; 2006 May; 236(1):1-12. PubMed ID: 15950375
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide phenotype analysis in ES cells by regulated disruption of Bloom's syndrome gene.
Yusa K; Horie K; Kondoh G; Kouno M; Maeda Y; Kinoshita T; Takeda J
Nature; 2004 Jun; 429(6994):896-9. PubMed ID: 15215867
[TBL] [Abstract][Full Text] [Related]
4. Bloom helicase is involved in DNA surveillance in early S phase in vertebrate cells.
Imamura O; Fujita K; Shimamoto A; Tanabe H; Takeda S; Furuichi Y; Matsumoto T
Oncogene; 2001 Mar; 20(10):1143-51. PubMed ID: 11313858
[TBL] [Abstract][Full Text] [Related]
5. Defective sister-chromatid cohesion, aneuploidy and cancer predisposition in a mouse model of type II Rothmund-Thomson syndrome.
Mann MB; Hodges CA; Barnes E; Vogel H; Hassold TJ; Luo G
Hum Mol Genet; 2005 Mar; 14(6):813-25. PubMed ID: 15703196
[TBL] [Abstract][Full Text] [Related]
6. Cancer predisposition caused by elevated mitotic recombination in Bloom mice.
Luo G; Santoro IM; McDaniel LD; Nishijima I; Mills M; Youssoufian H; Vogel H; Schultz RA; Bradley A
Nat Genet; 2000 Dec; 26(4):424-9. PubMed ID: 11101838
[TBL] [Abstract][Full Text] [Related]
7. Role of the BLM helicase in replication fork management.
Wu L
DNA Repair (Amst); 2007 Jul; 6(7):936-44. PubMed ID: 17363339
[TBL] [Abstract][Full Text] [Related]
8. Mismatch repair genes identified using genetic screens in Blm-deficient embryonic stem cells.
Guo G; Wang W; Bradley A
Nature; 2004 Jun; 429(6994):891-5. PubMed ID: 15215866
[TBL] [Abstract][Full Text] [Related]
9. Enhanced gene targeting efficiency by siRNA that silences the expression of the Bloom syndrome gene in human cells.
So S; Nomura Y; Adachi N; Kobayashi Y; Hori T; Kurihara Y; Koyama H
Genes Cells; 2006 Apr; 11(4):363-71. PubMed ID: 16611240
[TBL] [Abstract][Full Text] [Related]
10. Enhanced tumor formation in mice heterozygous for Blm mutation.
Goss KH; Risinger MA; Kordich JJ; Sanz MM; Straughen JE; Slovek LE; Capobianco AJ; German J; Boivin GP; Groden J
Science; 2002 Sep; 297(5589):2051-3. PubMed ID: 12242442
[TBL] [Abstract][Full Text] [Related]
11. Induction of renal tumorigenesis with elevated levels of somatic loss of heterozygosity in Tsc1+/- mice on a Blm-deficient background.
Wilson C; Idziaszczyk S; Colley J; Humphreys V; Guy C; Maynard J; Sampson JR; Cheadle JP
Cancer Res; 2005 Nov; 65(22):10179-82. PubMed ID: 16288003
[TBL] [Abstract][Full Text] [Related]
12. Loss of Bloom syndrome protein destabilizes human gene cluster architecture.
Killen MW; Stults DM; Adachi N; Hanakahi L; Pierce AJ
Hum Mol Genet; 2009 Sep; 18(18):3417-28. PubMed ID: 19542097
[TBL] [Abstract][Full Text] [Related]
13. Absence of BLM leads to accumulation of chromosomal DNA breaks during both unperturbed and disrupted S phases.
Li W; Kim SM; Lee J; Dunphy WG
J Cell Biol; 2004 Jun; 165(6):801-12. PubMed ID: 15197177
[TBL] [Abstract][Full Text] [Related]
14. Rothmund-Thomson syndrome and RECQL4 defect: splitting and lumping.
Larizza L; Magnani I; Roversi G
Cancer Lett; 2006 Jan; 232(1):107-20. PubMed ID: 16271439
[TBL] [Abstract][Full Text] [Related]
15. Acquired genomic aberrations associated with methotrexate resistance vary with background genomic instability.
Snijders AM; Hermsen MA; Baughman J; Buffart TE; Huey B; Gajduskova P; Roydasgupta R; Tokuyasu T; Meijer GA; Fridlyand J; Albertson DG
Genes Chromosomes Cancer; 2008 Jan; 47(1):71-83. PubMed ID: 17943968
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the BLM gene in ATM-null DT40 cells does not exacerbate either phenotype.
Fukao T; Chen P; Ren J; Kaneko H; Zhang GX; Kondo M; Yamamoto K; Furuichi Y; Takeda S; Kondo N; Lavin MF
Oncogene; 2004 Feb; 23(8):1498-506. PubMed ID: 14985700
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells.
Vernole P; Muzi A; Volpi A; Dorio AS; Terrinoni A; Shah GM; Graziani G
Mutat Res; 2009 May; 664(1-2):39-47. PubMed ID: 19428379
[TBL] [Abstract][Full Text] [Related]
18. BLM is required for faithful chromosome segregation and its localization defines a class of ultrafine anaphase bridges.
Chan KL; North PS; Hickson ID
EMBO J; 2007 Jul; 26(14):3397-409. PubMed ID: 17599064
[TBL] [Abstract][Full Text] [Related]
19. The distribution and expression of the Bloom's syndrome gene product in normal and neoplastic human cells.
Turley H; Wu L; Canamero M; Gatter KC; Hickson ID
Br J Cancer; 2001 Jul; 85(2):261-5. PubMed ID: 11461087
[TBL] [Abstract][Full Text] [Related]
20. Role for BLM in replication-fork restart and suppression of origin firing after replicative stress.
Davies SL; North PS; Hickson ID
Nat Struct Mol Biol; 2007 Jul; 14(7):677-9. PubMed ID: 17603497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
